(Q34707746)

4 August 2017

1 reference

title

Phytotherapeutic agents in the treatment of benign prostatic hyperplasia (English)

1 reference

4 August 2017

Dreikorn K

1

1 reference

4 August 2017

publication date

1 August 2000

1 reference

4 August 2017

published in

Current urology reports

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

103-109

1 reference

Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism

4 August 2017

cites work

1 reference

12 December 2020

Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group

1 reference

12 December 2020

Identification of a prostate inhibitory substance in a pollen extract

1 reference

12 December 2020

Phytotherapy in the treatment of benign prostatic hyperplasia: an update

1 reference

12 December 2020

Management of symptomatic BPH in the US: who is treated and how?

1 reference

12 December 2020

beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review

1 reference

12 December 2020

Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition

1 reference

12 December 2020

Phytotherapy for the prostate

1 reference

12 December 2020

Introduction and Concluding Remarks

1 reference

12 December 2020

Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.

1 reference

12 December 2020

Phytotherapy for treatment of benign prostatic hyperplasia: case not proven

1 reference

12 December 2020

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

1 reference

12 December 2020

Treatment of benign prostatic hyperplasia with phytosterols

1 reference

12 December 2020

[Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II). Comparison of therapeutic effectiveness in a one year double-blind study]

1 reference

12 December 2020

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils

1 reference

12 December 2020

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms

1 reference

12 December 2020

Effects of tadenan pretreatment on bladder physiology and biochemistry following partial outlet obstruction

1 reference

12 December 2020

Who should be treated and how? Evidence-based medicine in symptomatic BPH

1 reference

12 December 2020

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies

1 reference

12 December 2020

Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study

1 reference

12 December 2020

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

12 December 2020

Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells

1 reference

12 December 2020

Protective effect of Tadenan on bladder function secondary to partial outlet obstruction

1 reference

12 December 2020

[The effectiveness of beta-sitosterol in treatment of benign prostatic hyperplasia]

1 reference

12 December 2020

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

12 December 2020

[Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia]

1 reference

12 December 2020

Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia

1 reference

12 December 2020

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

12 December 2020

Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

Usefulness of Cernilton in the treatment of benign prostatic hyperplasia

1 reference

12 December 2020

[Guideline by German urologists on therapy of benign prostatic hypertrophy syndrome. German SOciety of Urology]

1 reference

12 December 2020

A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.

1 reference

12 December 2020

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

12 December 2020

Phytotherapy in treatment of benign prostatic hyperplasia: a critical review

1 reference

12 December 2020

10.1007/S11934-000-0044-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1048044342

0 references

1 reference